Neovasc Inc. Revenue

Revenue of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Revenue growth rates and interactive chart. Revenue is the income generated from normal business operations and includes discounts and deductions for returned merchandise. It is the top line or gross income figure from which costs are subtracted to determine net income.


Highlights and Quick Summary

  • Revenue for the quarter ending March 31, 2022 was $611 Thousand (a -18.96% decrease compared to previous quarter)
  • Year-over-year quarterly Revenue decreased by -2.58%
  • Annual Revenue for 2021 was $2.51 Million (a 21.65% increase from previous year)
  • Annual Revenue for 2020 was $2.07 Million (a -3.19% decrease from previous year)
  • Annual Revenue for 2019 was $2.14 Million (a 28.09% increase from previous year)
  • Twelve month Revenue ending March 31, 2022 was $2.69 Million (a 6.19% increase compared to previous quarter)
  • Twelve month trailing Revenue increased by 20.33% year-over-year
Trailing Revenue for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$2.69 Million $2.53 Million $2.31 Million $2.23 Million
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Revenue of Neovasc Inc.

Most recent Revenueof NVCN including historical data for past 10 years.

Interactive Chart of Revenue of Neovasc Inc.

Neovasc Inc. Revenue for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.61
2021 $0.75 $0.7 $0.63 $0.45 $2.51
2020 $0.53 $0.63 $0.28 $0.53 $2.07
2019 $0.57 $0.5 $0.44 $0.59 $2.14
2018 $0.52 $0.48 $0.41 $0.34 $1.67
2017 $1.23 $1.37 $1.31 $1.48 $5.6
2016 $2.76 $3.03 $1.71 $2.01 $9.51
2015 $2.22 $2.48 $2.93 $2.3 $9.93
2014 $2.67 $3.77 $4.03 $3.48 $14.37
2013 $3.22 $3.5 $2.73 $2.0 $11.41
2012 $2.47 $2.02 $1.62 $1.71 $7.82
2011 $1.8 $5.25

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.